Table 2.
CCC SVD | CCC KW-SVD | NRMSE SVD (%) | NRMSE KW-SVD (%) | |
---|---|---|---|---|
T1 1.5 T | ||||
2D radial | 0.99 | 0.98 | 10.26 | 11.0 |
2D spiral | 0.99 | 0.99 | 8.4 | 8.5 |
3D radial | 0.99 | 0.99 | 9.4 | 6.6 |
3D spiral | 0.99 | 0.99 | 5.6 | 4.2 |
T2 1.5 T | ||||
2D radial | 0.99 | 0.99 | 14.7 | 11.1 |
2D spiral | 0.99 | 0.99 | 11.6 | 9.0 |
3D radial | 0.99 | 0.99 | 15.3 | 10.5 |
3D spiral | 0.98 | 0.98 | 7.0 | 4.9 |
T1 3 T | ||||
2D radial | 0.99 | 0.98 | 8.3 | 10.1 |
2D spiral | 0.99 | 0.98 | 6.2 | 10.4 |
3D radial | 0.99 | 0.99 | 9.5 | 8.7 |
3D spiral | 0.99 | 0.99 | 7.7 | 6.4 |
T2 3 T | ||||
2D radial | 0.99 | 0.99 | 13.5 | 10.1 |
2D spiral | 0.92 | 0.94 | 13.5 | 12.7 |
3D radial | 0.99 | 0.99 | 13.7 | 11.0 |
3D spiral | 0.97 | 0.98 | 9.6 | 7.6 |
NRMSE normalization were calculated with respect to the average nominal value of the vials.